COMS

Ein Tagungskalender für Wissenschaftler und Ingenieure

Startseite | Konferenzservice | Konferenzkalender | Werbung | Kontakt | Impressum
deutsch französisch englisch
Pfad: StartseiteKonferenzkalenderBiowissenschaften → Biotechnologie in den Vereinigten Staaten (USA)

Konferenzmanagement Software

Unser Konferenzmanagement-
system (COMS)
kann Ihr Leben leichter machen!

Als Organisator einer Tagung benutzen Sie COMS um:

  • Teilnehmer-
    anmeldungen
  • Zahlungen
  • Vortrags-
    ankündigungen
  • Begutachtung, Redaktion und Auswahl der Vortrags-
    anmeldungen

online anzubieten bzw. durchzuführen.

Mehr Info

Konferenzen zum Thema Biotechnologie in den Vereinigten Staaten (USA)

Conference-Service.com stellt der Öffentlichkeit ein Kalendarium wichtiger Konferenzen, Symposien und sonstiger Tagungen im wissenschaftlich-technischen Bereich zur Verfügung. Obwohl das Verzeichnis mit großer Sorgfalt zusammengestellt und ständig aktualisiert wird, weisen wir auf die Möglichkeit von Fehlern ausdrücklich hin. Bitte vergewissern Sie sich immer beim Veranstalter, bevor Sie über die Teilnahme oder Nichtteilnahme an einer Konferenz entscheiden.

Organisatoren können kostenlos ihre Konferenzankündigungen veröffentlichen.

1.Metabolomics2012
 Termin 20. Feb 2012 → 22. Feb 2012
[ID=450019] Zum Seitenanfang gehen
 OrtBurlingame, Vereinigte Staaten
 Zusammenfassung Metabolomics-2012 will serve as a catalyst for the advances in the study of Metabolomics & Systems Biology by connecting scientists within and across disciplines at sessions and exhibition held at the venue, creates an environment conducive to information exchange, generation of new ideas, and acceleration of applications that benefit Research in Metabolomics & Systems Biology.
 Themen metabolomics and system biology
 Webseite http://www.omicsonline.org/metabolomics2012/
 Kontakt Tel.: (Toll free: 1-800-216-6499); Email: metabolomics2012@omicsonline.org
 Verwandte Fachgebiete Molekularbiologie; Biologie
2.2nd Ubiquitin Research and Drug Discovery Conference
 Termin 27. Feb 2012 → 28. Feb 2012
[ID=453848] Zum Seitenanfang gehen
 OrtLas Vegas, Vereinigte Staaten
 Zusammenfassung The field of ubiquitin research has been growing as most big pharma companies have shown interest enough to develop ubiquitin research in their pipeline. The industry has determined that there is a huge potential in the development of therapeutics. Though ubiquitin research may be considered a small community, many have seen the growth and diversity of the field to project that the field is ready to blow up in the next few years. To stay ahead of the curve, it will require you to stay on top of recent technological advancements and development trends.

GTC is proud to present our 2nd Annual Ubiquitin Research and Drug Development Conference! This meeting, taking place on February 27-28, 2012 at the Red Rock Resort & Spa in Las Vegas, NV, will bring together leaders from biotech and pharmaceutical companies, academia, and government, to provide you with a solid primer for a better understanding of the complex activities of ubiquitin and ubiquitin-like proteins and some solutions to the challenges associated with ubiquitin drug development.

 Webseite http://www.gtcbio.com/component/conference/?file=home&cn=2nd+Ubiquitin+Research+and+Drug+Discovery&cid=13
 Kontakt Global Technology Community, 434 W. Foothill Blvd, Monrovia, CA 91016, Phone: 626-256-6405, Fax: 626-466-4433; Email: may.lee@gtcbio.com
 Verwandte Fachgebiete Pharmakologie und Arzneimittelentwicklung
3.Institute of Biological Engineering 2012 Annual Conference
 Termin 01. Mär 2012 → 03. Mär 2012
[ID=460191] Zum Seitenanfang gehen
 OrtIndianapolis, Indiana, Vereinigte Staaten
 Zusammenfassung The Institute of Biological Engineering (IBE) was established to encourage inquiry and interest in biological engineering.

The 21st century presents global challenges in the environment, resources, energy, health, and sustainability. The Institute of Biological Engineering supports the community of scientists and engineers that are addressing these problems through biological systems analysis and design. We do this through enhancing and promoting biological engineering in the broadest manner through research, education, and professional development.

The emerging discipline of biological engineering lies at the interfaces of biological sciences, engineering sciences, mathematics and computational sciences. It applies biological systems to enhance of the quality and diversity of life.

 Themen Bioengineering, Biology, Research Methods, Synthetic Biology
 Webseite http://www.ibe.org/
 Verwandte Fachgebiete Biologie; Nahrungsmittelchemie und Agrarwissenschaften
  
4.Biomarker and Diagnostic Conference
 Termin 15. Mär 2012 → 16. Mär 2012
[ID=444460] Zum Seitenanfang gehen
 OrtSan Diego, Vereinigte Staaten
 Zusammenfassung GTC is proud to present the Biomarker and Diagnostics Conference as part of the Biomarker Summit 2012. Providing attendees a comprehensive study of using biomarkers as a diagnostic tool, this inaugural Conference focuses on this specific issue without sidetracking into other areas of contemporary research. Diagnostics is a powerful tool in pharmaceutical development and the battle against disease. Providing attendees with one of the few opportunities to focus exclusively on diagnostics, attendees will benefit by gaining knowledge of today's latest developments by industry experts. Beyond simply attending a conference, attendees will be part of the larger Biomarker Summit 2012 that also includes:
4th Oncology Biomarker Conference
6th Biomarker Development Conference
Biomarker Partnering and Deal-Making Conference Limitless networking opportunities will be provided for attendees across all four Summit tracks. We look forward to welcoming you to the Biomarker Summit 2012! The Conference features the following sessions: Plenary Session Regulatory & Policy Update Keynote Speaker Biomarker and Diagnostics Next Generation Sequencing and Discovery of New Diagnostics (Dual Track) Personalized Medicine for non-oncology uses (Dual Track) Patient Selection & Stratification in the Design of Clinical Trials for New Diagnostics Novel Approaches & Emerging Technologies for Diagnostics Companion Diagnostics ?New DNA Companion Diagnostics ?New Protein Companion Diagnostics Circulating/Body Fluid Biomarkers Developments Novel methods for Prediction Algorithms
 Webseite http://www.gtcbio.com/component/conference/?file=home&cn=Biomarker+and+Diagnostic+Conference&cid=66
 Verwandte Fachgebiete Pharmakologie und Arzneimittelentwicklung
  
5.4th Oncology Biomarkers Conference
 Termin 15. Mär 2012 → 16. Mär 2012
[ID=444514] Zum Seitenanfang gehen
 OrtSan Diego, Vereinigte Staaten
 Zusammenfassung Providing attendees a comprehensive study of using biomarkers as a diagnostic tool, this inaugural Conference focuses on this specific issue without sidetracking into other areas of contemporary research. Diagnostics is a powerful tool in pharmaceutical development and the battle against disease. Providing attendees with one of the few opportunities to focus exclusively on diagnostics, attendees will benefit by gaining knowledge of today's latest developments by industry experts.
 Webseite http://www.gtcbio.com/component/conference/?file=home&cn=4th+Oncology+Biomarkers+Conference&cid=64
 Verwandte Fachgebiete Pharmakologie und Arzneimittelentwicklung
  
6.6th Biomarker Development Conference
 Termin 15. Mär 2012 → 16. Mär 2012
[ID=444491] Zum Seitenanfang gehen
 OrtSan Diego, Vereinigte Staaten
 Zusammenfassung Returning for its sixth installment, the Conference will once again be the gathering center for professionals in the biomarker development industry. Biomarker Development remains one of the most important aspects in the pharmaceutical industry and will continue to push advancements well into the future. As the nearly $13 billion biomarker market continues to advance, its complexity grows as well. It is essential that the industry is in tune with the latest developments and breakthroughs, especially in the current economic and regulatory environment. Only those armed with the highest caliber intelligence will be able to compete and continue to contribute to this vital industry.

The 6th Biomarker Development Conference offers attendees insight into the latest developments from the leading players will offering a unique networking opportunity.

 Webseite http://www.gtcbio.com/component/conference/?file=home&cn=6th+Biomarker+Development+Conference&cid=69
 Verwandte Fachgebiete Pharmakologie und Arzneimittelentwicklung
  
7.Biomarker Partnering and Deal-Making Conference
 Termin 15. Mär 2012 → 16. Mär 2012
[ID=444589] Zum Seitenanfang gehen
 OrtSan Diego, Vereinigte Staaten
 Zusammenfassung Closing in on becoming a $13 billion industry, biomarker advancements require new investments while offering the potential for significant returns. While both developers and investors are seeking the strongest partnerships, only those with the deepest understanding of both scientific and business issues will succeed.

Offering a unique opportunity, the Biomarker Partnering and Deal-Making Conference assembles leading players to discuss what needs to be accomplished to lead the industry into its next phase. The business of biomarkers has reached an exciting and critical stage and intelligence and strategic relationship building is more important than ever. Attendees will be able to set the stage for both at this leading event.

 Webseite http://www.gtcbio.com/component/conference/?file=home&cn=Biomarker+Partnering+and+Deal-Making+Conference&cid=70
 Verwandte Fachgebiete Pharmakologie und Arzneimittelentwicklung
  
8.SMBE Satellite Symposium on Phylomedicine
 Termin 23. Mär 2012 → 24. Mär 2012
[ID=450326] Zum Seitenanfang gehen
 OrtTempe, Arizona, Vereinigte Staaten
 Zusammenfassung Arizona State University is hosting a symposium on Phylomedicine to be held March 23-24, 2012 in Tempe, Arizona. This symposium is sponsored by the SMBE to bring together scientific leaders at the intersection of Molecular Evolution and Genomic Medicine (Phylomedicine). Attendance is capped at 100 participants in order to allow enhanced discussion and information exchange. Visit the website for more information on the conference and to complete the registration form. (Sudhir Kumar, conference organizer)
 Themen phylomedicine, genome, medicine, molecular evolution, genome, evolution, biotech, biotechnology, bioinformatics, smbe
 Webseite http://www.smbe.org/phylomed/
 Verwandte Fachgebiete Medizin (allgem.); Molekularbiologie
  
9.8th Stem Cell Summit
 Termin 19. Apr 2012 → 20. Apr 2012
[ID=454529] Zum Seitenanfang gehen
 OrtBoston, Vereinigte Staaten
 Zusammenfassung 8th Stem Cell Summit includes two concurrent tracks (Track 1: Stem Cell Research & Regenerative Medicine, Track 2: Stem Cell Commercialization & Partnering). This summit provides cutting-edge information on developments in all areas of stem cell research including the biology, medicine, applications, regulations, and the business of Stem Cells.

Recent developments in pre-clinical and clinical trials of stem cell therapy, regenerative medicine and tissue engineering, cancer stem cells, stem cell reprogramming, and regulatory policies regarding stem cell research will be addressed. In addition, focuses on the business opportunities, challenges and potential strategies for overcoming these challenges will be addressed. What categories of companies are currently commercially viable? How are they being funded? What kind of strategic relationships are available within the industry?

 Webseite http://www.gtcbio.com/index.php?option=com_conference&file=home&cn=8th Stem Cell Summit&cid=22
 Kontakt Email: infogtcbio@gtcbio.com
  
10.SBE's 3rd International Conference on Stem Cell Engineering
 Termin 29. Apr 2012 → 02. Mai 2012
[ID=453893] Zum Seitenanfang gehen
 OrtSeattle, Vereinigte Staaten
 Webseite http://stemcell.aiche.org/
  
11.Third International 'Frontiers in Synthetic Biology, Biofuels & Green Chemistry-2012- Meeting' On 'Synthetic Genomes to Biofuels & Renewable Clean Energy Production'
 Termin 01. Mai 2012 → 02. Mai 2012
[ID=462202] Zum Seitenanfang gehen
 OrtWaltham, Vereinigte Staaten
 Themen Synthetic Genomics & Organelle Synthesis,
 Webseite http://www.expressgenes.com
 Kontakt PO Box 540179 Waltham, MA 02451 USA; Tel.: [7818918181]; Email: sham@expressgenes.com
 Verwandte Fachgebiete Biochemie und Medizinische Chemie
  
12.2012 AAPS National Biotechnology Conference
 Termin 21. Mai 2012 → 23. Mai 2012
[ID=445198] Zum Seitenanfang gehen
 OrtSan Diego, Vereinigte Staaten
 Webseite http://www.aaps.org/nationalbiotech/
  
13.2nd World Lyophilization
 Termin 29. Mai 2012 → 30. Mai 2012
[ID=466146] Zum Seitenanfang gehen
 OrtBoston, MA, Vereinigte Staaten
 Zusammenfassung Drug Developers Come Together to Discuss How To Optimize the Lyophilization Process
 Themen Lyophilization. Drug development Freeze Drying Science Biotech Biotechnology
 Webseite http://lyophilization-summit.com/
 Kontakt shirelle haines; Tel.: [+44 (0)20 3141 8700]; Email: shirelle.haines@hansonwade.com
 Verwandte Fachgebiete Pharmakologie und Arzneimittelentwicklung
  
14.Bioanalytical Sensors
 Termin 17. Jun 2012 → 22. Jun 2012
[ID=454930] Zum Seitenanfang gehen
 OrtNewport, RI, Vereinigte Staaten
 Veranstalter Gordon Research Conferences
 Zusammenfassung The 2012 GRC on Bioanalytical Sensors (June 17-22, Salve Regina) will present cutting-edge research in a highly multidisciplinary atmosphere by leaders in the field. This GRC will serve as a conduit for collegial discussions of unpublished data in biochemistry, biology, chemistry, engineering, medicine, and physics as they apply to the development and applications of bioanalytical sensors. This meeting will bring together a diverse group of participants ranging from technologists, who are at the forefront of developing novel sensing platforms, to engineers with cutting-edge integration concepts, to biologists/clinicians with highly impactful application areas that demand new sensing systems. Research themes that will be discussed in this GRC include: 1) novel recognition elements and reporters, 2) recent advances in optical, electrochemical, and mechanical detection, 3) real-world applications including in vivo sensing, 4) the use of nanotechnology to advance the understanding of molecular interactions and integration into sensor designs enabling novel applications, and 5) system integration technologies. Specific topical areas that will be covered include (but are not limited to), single molecule-based sensing, intracellular sensing, biomaterials with enhanced optical or electronic properties, nanomaterials, nanostructures, engineered surfaces, miniaturization and automation, and multiplexed detection in complex matrices. This GRC will also provide for informal discussions on funding opportunities in the area of bioanalytical sensors and strategies for the commercialization of new platform technologies.

The collegial atmosphere of this GRC with ample time for discussion during the oral sessions as well as opportunities for discussions during informal gatherings in the afternoons and evenings provides an avenue for scientists/engineers from diverse disciplines to brainstorm and promote new cross-disciplinary collaborations in the various research areas represented.

In addition, the Gordon Research Seminar (GRS) will convene immediately preceding the GRC (15 - 16 June 2012). Organized and conducted by graduate students and postdocs, the GRS will provide an opportunity for junior scientists to present their work in a formal and oral or poster format in front of their peers. These students will participate in the subsequent Bioanalytical Sensors GRC providing a unique opportunity to promote interactions between future researchers and established ones.

 Webseite http://www.grc.org/programs.aspx?year=2012&program=biosens
 Verwandte Fachgebiete Messtechnik
  
15.2012 BIO International Convention
 Termin 18. Jun 2012 → 21. Jun 2012
[ID=460158] Zum Seitenanfang gehen
 OrtBoston, Massachusetts, Vereinigte Staaten
 Themen Biologics, Biotechnology, Clinical Research, Clinical Trials, Corporate Science, Drug Discovery/Development, Health Economics, Health Policy, Industrial Laboratories, Personalized Medicine, Pharmaceutical Sciences, Regulatory Affairs
 Webseite http://convention.bio.org/#
  
16.Musculoskeletal Biology & Bioengineering — Musculoskeletal Science: Bedside to Bench to Bedside
 Termin 05. Aug 2012 → 10. Aug 2012
[ID=455761] Zum Seitenanfang gehen
 OrtAndover, NH, Vereinigte Staaten
 Veranstalter Gordon Research Conferences
 Zusammenfassung The Gordon Research Conference on Musculoskeletal Biology and Bioengineering (previously titled Bioengineering and Orthopaedic Sciences) has been the premier forum for presentation and discussion of new and unpublished information in the field, and has consistently led to new insights, new interactions, new collaborations, and new research directions. The study of the musculoskeletal system encompasses a number of interdisciplinary fields, particularly biology and bioengineering, and has ultimate applications in clinical areas including orthopaedic surgery, rheumatology, and radiology. The theme of the planned 2012 conference is "Musculoskeletal Science: Bedside to Bench to Bedside," and the meeting will consist of 9 separate sessions, consisting of invited speakers who are experts in their field and selected attendees at various levels of career development. The format of the planned conference remains essentially unchanged from previous years, with ample time for formal and informal discussions. Our unique focus in 2012 is to facilitate the physician-scientist interaction to bring new ideas and treatments to improve the lives of patients. This is exemplified by our session on Translational Studies on Enhancing Soft Tissue Healing, with both physicians and scientists lecturing together on cutting edge solutions and investigations into clinical problems. Some of the chief issues are specific to individual tissues, including bone, articular cartilage, intra-articular ligament, meniscus, and both rotator cuff and flexor tendons, as well as other multi-tissue skeletal structures. A number of key scientific and engineering topics are relevant to fabrication and manipulation of these tissues and organs. The conference will examine many of these topics, including biomaterial fabrication, stem cells, biomarkers, skeletal development, growth and regeneration, and translation of basic research to clinical practice. In addition, the conference also includes several high-profile research areas highlighting the close collaboration required between clinician-scientists and PhDs to improve patients' health outcomes.
 Webseite http://www.grc.org/programs.aspx?year=2012&program=musculo
 Verwandte Fachgebiete Medizin (allgem.)
  
17.62nd Annual Meeting of the Society for Industrial Microbiology and Biotechnology
 Termin 12. Aug 2012 → 16. Aug 2012
[ID=463452] Zum Seitenanfang gehen
 OrtWashington, DC, Vereinigte Staaten
 Webseite http://www.simhq.org/annual/
  
18.BPA — BioPharm America 2012
 Termin 19. Sep 2012 → 21. Sep 2012
[ID=440492] Zum Seitenanfang gehen
 OrtBoston, Vereinigte Staaten
 Zusammenfassung BioPharm America is where biotech industry partnerships get started. This three-day conference provides a proven and highly productive format for establishing new business relationships. Meet face-to-face with biotech and pharma executives from around the world to identify and enter strategic relationships. Equipped with partneringONE®, the world?s leading web-based partnering system for the life science industry, BioPharm America is the only event in North America based on the same reputable formula as EBD Group?s acclaimed European events BIO-Europe® and BIO-Europe Spring®. In 2011, BioPharm America attracted 950+ delegates from 588 companies who participated in 2,550+ scheduled one-to-one meetings.
 Themen partnering, business development, biotech, pharmaceutical, medical device, diagnostic, licensing, finance
 Webseite http://www.ebdgroup.com/bpa
 Kontakt Tel.: (+1 (760) 930-0500); Email: chundschell@ebdgroup.com
 Verwandte Fachgebiete Pharmakologie und Arzneimittelentwicklung
  

Alle Konferenzen in den Vereinigten Staaten (USA) anzeigen.

Stand vom 02. Februar 2012